Replay available

Evolent Health, Inc. (EVH) Q4 2025 Earnings Call

Evolent Health, Inc. (NYSE: EVH) Q4 2025 earnings conference call, held 2026-02-24. Replay captured from the company's public earnings webcast.

Tue, February 24, 2026 at 5:00 PMendedReplay
Evolent Health, Inc. (EVH) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Seth Blackley

Chief Executive Officer

Mario Ramos

Chief Financial Officer

John Stancil

Analyst, JP Morgan

Daniel Grossleit

Analyst, Citi

Jalendra Singh

Analyst, Truist Securities

Jared Haas

Analyst, William Blair

Jessica Tasson

Analyst, Piper Sandler

Jeff Garra

Analyst, Stevens

Matthew Gilmore

Analyst, KeyBank

Richard Close

Analyst, Canaccord Genuity

David Larson

Analyst, BTIG

Matthew Shea

Analyst, Needham

Sean Dodge

Analyst, BMO Capital Markets

Kevin Caliendo

Analyst, UBS

Ryan Halstead

Analyst, RBC Capital Markets

Replay transcript excerpt

Welcome to the Evelyn Earnings conference call for the fourth quarter ended December 31st, As a reminder, this conference call is being recorded. Your hosts for today's call are Evelyn, Seth Blackley, Chief Executive Officer, and Mario Ramos, Chief Financial Officer. This call will be archived and available later this evening and for the next week via the webcast on the company's website in the section titled Investor Relations. This conference call will contain forward-looking statements under the U.S. federal laws and These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of these risks and uncertainties can be found in the company's reports that are filed with the Securities and Exchange Commissions, including cautionary statements including in our current and periodic filings. For additional information on the company's results and outlook, please refer to our third quarter press release issued earlier today. Finally, as a reminder, reconciliations of non-GAAP measures discussed during today's call to the most directly comparable GAAP measures are available in the summary presentation available in the Investor Relations section of our website or in the company's press release issued today and posted in the Investors Relations website, ir.evident.com, and the Form 8-K filed by the company with the SEC earlier today. In addition to reconciliations, we provide details on the numbers and operating metrics for the quarter in both our press release and supplemental investor presentation. And now I will turn the call over to Evelyn's CEO, Seth Blackley. Good evening and thank you for joining us. Earlier today, we released strong Q4 results with...

More from Evolent Health, Inc